These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 7638794
21. [The role of immediate-type allergic reactions in the pathogenesis of the nephrotic syndrome]. Shishkin AN. Ter Arkh; 1996; 68(6):19-21. PubMed ID: 8771676 [Abstract] [Full Text] [Related]
22. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis]. Zhang FC, Zhou B, Dong Y. Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001 [Abstract] [Full Text] [Related]
23. [The significance of antiendothelial cell antibodies in patients with lupus nephritis: a clinical and renal pathological study]. Geng H, Zhang Y, Zhao M. Zhonghua Yi Xue Za Zhi; 1999 Jan 13; 79(1):31-3. PubMed ID: 11601003 [Abstract] [Full Text] [Related]
24. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM. Arthritis Rheum; 2004 Aug 13; 50(8):2569-79. PubMed ID: 15334471 [Abstract] [Full Text] [Related]
25. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications. Nojima J, Suehisa E, Kuratsune H, Machii T, Koike T, Kitani T, Kanakura Y, Amino N. Thromb Haemost; 1999 Mar 13; 81(3):436-41. PubMed ID: 10102474 [Abstract] [Full Text] [Related]
26. Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study. Chrysochou C, Randhawa H, Reeve R, Waldek S, Wood GN, O'Donoghue DJ, Kalra PA. QJM; 2008 Apr 13; 101(4):313-6. PubMed ID: 18270227 [Abstract] [Full Text] [Related]
27. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. Pradhan VD, Badakere SS, Bichile LS, Almeida AF. J Assoc Physicians India; 2004 Jul 13; 52():533-7. PubMed ID: 15645975 [Abstract] [Full Text] [Related]
28. Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary. Brugos B, Kiss E, Szodoray P, Szegedi G, Zeher M. Scand J Immunol; 2006 Oct 13; 64(4):433-7. PubMed ID: 16970686 [Abstract] [Full Text] [Related]
29. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN. Clin Nephrol; 1996 Sep 13; 46(3):170-5. PubMed ID: 8879851 [Abstract] [Full Text] [Related]
30. Immunohistochemical detection of intravascular platelet microthrombi in patients with lupus nephritis and anti-phospholipid antibodies. Galindo M, Gonzalo E, Martinez-Vidal MP, Montes S, Redondo N, Santiago B, Loza E, Pablos JL. Rheumatology (Oxford); 2009 Aug 13; 48(8):1003-7. PubMed ID: 19542214 [Abstract] [Full Text] [Related]
31. [Prognostic factors in children with lupus nephritis]. Wikiera-Magott I, Medyńska A, Zwolińska D. Wiad Lek; 2005 Aug 13; 58 Suppl 1():50-4. PubMed ID: 16060085 [Abstract] [Full Text] [Related]
32. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis]. Kiss E, Fazekas B, Tarr T, Muszbek L, Zeher M, Szegedi G. Orv Hetil; 2004 Feb 01; 145(5):217-22. PubMed ID: 15024932 [Abstract] [Full Text] [Related]
33. [Lupus nephritis: clinico-morphologic correlation]. Perunicić G, Djukanović Lj, Pljesa S, Sević L. Srp Arh Celok Lek; 1996 Feb 01; 124 Suppl 1():64-7. PubMed ID: 9102935 [Abstract] [Full Text] [Related]
35. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, Li Vecchi M, Messa P, Sinico RA. Ann Rheum Dis; 2009 Feb 01; 68(2):234-7. PubMed ID: 18718989 [Abstract] [Full Text] [Related]
36. [Systemic lupus erythematosus in men--a different prognosis?]. Specker C, Becker A, Lakomek HJ, Bach D, Grabensee B. Z Rheumatol; 1994 Feb 01; 53(6):339-45. PubMed ID: 7871906 [Abstract] [Full Text] [Related]
37. Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre. Vachvanichsanong P, Dissaneewate P, McNeil E. Nephrol Dial Transplant; 2009 Sep 01; 24(9):2729-34. PubMed ID: 19395731 [Abstract] [Full Text] [Related]
38. Symptomatic thrombotic events among Egyptian patients with systemic lupus erythematosus: special consideration for renal vein thrombosis. Shahin AA, Mostafa H, Sami H, Shahin HA. Z Rheumatol; 2003 Jun 01; 62(3):246-50. PubMed ID: 12827401 [Abstract] [Full Text] [Related]
39. Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage. Funauchi M, Ikoma S, Imada A, Kanamaru A. J Clin Lab Immunol; 1997 Jun 01; 49(2):47-57. PubMed ID: 9819673 [Abstract] [Full Text] [Related]
40. Anticardiolipin antibodies in South African patients with lupus nephritis: a clinical and renal pathological study. Naiker IP, Rughubar KN, Duursma J, Pudifin DJ, Seedat YK. Am J Nephrol; 2000 Jun 01; 20(5):351-7. PubMed ID: 11092990 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]